🇺🇸 1.5% levofloxacin ophthalmic solution in United States

FDA authorised 1.5% levofloxacin ophthalmic solution on 1 March 2004

Marketing authorisations

FDA — authorised 1 March 2004

  • Application: NDA021571
  • Marketing authorisation holder: SANTEN
  • Local brand name: IQUIX
  • Indication: SOLUTION/DROPS — OPHTHALMIC
  • Status: approved

Read official source →

FDA

  • Status: approved

1.5% levofloxacin ophthalmic solution in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 1.5% levofloxacin ophthalmic solution approved in United States?

Yes. FDA authorised it on 1 March 2004; FDA has authorised it.

Who is the marketing authorisation holder for 1.5% levofloxacin ophthalmic solution in United States?

SANTEN holds the US marketing authorisation.